Perez Okade J. Rojas L. Reynolds Ballesté-Delpierre Tsen

91 MONDAY SCIENTIFIC SESSIONS Final Program C1-680 Cumulative Resistance to the Novel Lpxc Inhibitor Chir-090 in Pseudomonas aeruginosa: Interplay of Efflux and Non Efflux Mechanisms

A. K. Jones

1 , S. Barnes 2 , K. Suefuji 1 , L. Xie 1 , J. R. Walker 2 , C. R. Dean 1 ; 1 Novartis Inst. for Biomedical Res., Emeryville, CA, 2 Genomics Inst. of the Novartis Res. Fndn., San Diego, CA. C1-681 Ozenoxacin. Selection of Resistant Mutants of Gram-Posi- tive Cocci

Y. López, Biologist

1 , M. Tato 2 , R. Cantón 2 , J. Vila 1 ; 1 Hosp. Clinic, Barce- lona, Spain, 2 Ramón y Cajal Univ. Hosp., Madrid, Spain. C1-682 Ozenoxacin Impact of Mutations in the gyrA y parC Genes of Clinical Gram-Positive Cocci in the MIC

Y. López

1 , M. Tato 2 , R. Cantón 2 , J. Vila 1 ; 1 Hosp. Clinic, Barcelona, Spain, 2 Ramón y Cajal Univ. Hosp., Madrid, Spain. C1-683 Prevalence and Molecular Characterization of Plasmid-Me- diated Quinolone Resistance in Prospective Bacteremic Clinical Isolates of Enterobacter spp. from Spain

J. Rodriguez-Martinez

1 , P. Díaz de Alba 1 , C. Ruiz de Alegría 2 , C. Martín- Gandul 3 , O. Gasch 4 , M. Cano 2 , F. Tubau 4 , J. Lepe 3 , R. Lara 5 , F. Rodriguez 5 , J. Rodriguez-Baño 1 , L. Martinez-Martinez 2 , M. Jiménez-Mejías 3 , A. Pascual 1 ; 1 Univ. of Seville, Seville, Spain, 2 UH Marques de Valdecilla, Santander, Spain, 3 UH Virgen del Rocio, Seville, Spain, 4 UH Bellvitge, Barcelona, Spain, 5 UH Reina Sofia, Cordoba, Spain. Late-breaker presentations are listed behind the Late-breaker tab of the Final Program. ------------------------------------------------------------------------ 087 C2 Poster Session Diverse Resistance Issues in Enterobacteriaceae Monday, 11:15 a.m.–1:15 p.m. . . . . . . . . . . . . . . . . . . . Halls A-C Presentations: C2-684 Host Risk Factors and Efflux Pump Gene Expressions Among E.coli Strains Isolated From Community-Acquired Urinary Tract Infections

F. Can

1 , O. Kurt Azap 2 , I. Dolapci 3 , A. Yesilkaya 2 , H. Arslan 2 , O. Ergonul 1 ; 1 Koc Univ., Istanbul, Turkey, 2 Baskent Univ., Ankara, Turkey, 3 Ankara Univ., Ankara, Turkey. C2-685 Antimicrobial Resistance and Virulence Markers of E. coli Isolated from Nosocomial Bloodstream Infection: A Study of the SCOPE Brazil Project A. C. Rochstroh, A. M. Doi, R. M. Silva, A. R. Marra, A. C. C. Pignatari; UNIFESP, Sao Paulo, Brazil. C2-686 Molecular Study of Escherichia coli Isolates from Outbreak of Infections After Transrectal Ultrasound-Guided Prostate Biopsy

N. Suwantarat

1 , S. Rudin 2 , D. Dumford 1 , S. Marshall 2 , A. M. Hujer 2 , K. M. Hujer 2 , R. A. Bonomo 2 , C. J. Donskey 2 ; 1 Case Western Reserve Univ., Cleveland, OH, 2 Louis Stokes VA Med. Ctr., Cleveland, OH. C2-687 Temporal Trends in Antibiotic Resistance among E. coli ST131 Isolates, 1968-2012

B. Olesen

1,2 , F. Scheutz 2 , J. Frimodt-Møller 1 , B. Johnston 3 , D. S. Hansen 1 , K. A. Krogfelt 2 , J. R. Johnson 3 ; 1 Hillerød Hosp., Hillerød, Denmark, 2 Statens Serum Inst., Copenhagen, Denmark, 3 VA Med. Ctr., Minneapolis, MN. C2-688 Regional Differences in Susceptibility of E. coli in Community-Acquired Versus Hospital-Associated Intra-Abdom- inal Infections: SMART 20102011

R. Badal, S. Lob, S. Bouchillon, M. Hackel, D. Hoban; IHMA, Inc., Schaumburg, IL.

C2-689 Risk Factors for 3rd Generation Cephalosporin Resistant Community Onset

E. coli Infections from Seven Centres in Low Prevalence Countries

B. A. Rogers

1,2 , P. R. Ingram 2,3 , N. Runnegar 2,4 , J. T. Freeman 2,5 , M. C. Pitman 2,6 , E. Athan 2,7 , S. Havers 1 , D. L. Paterson 1,2 ; 1 Univ. of Queensland, UQCCR, Brisbane, Australia, 2 The COOEE Study Group, ASID Clinical Res. Network, Qld, Australia, 3 The Royal Perth Hosptial, Perth, Australia, 4 Princess Alexandra Hosp., Woolloongabba, Australia, 5 Auckland District Hlth. Board, Auckland, New Zealand, 6 The Royal Darwin Hosp., Tiwi, Australia, 7 Barwon Hlth., Geelong, Australia. C2-690 Molecular Epidemiology of Non-Nosocomial Klebsiella pneumoniae Bloodstream KpB Infections M. Cubero, I. Grau, R. Pallares, J. Ayats, M. Cisnal, J. Liñares, C. Ardanuy; Hosp. Univ. Bellvitge, L´Hospitalet de Llobregat Barcelona, Spain. C2-691 New OXY-Variants from Klebisiella oxytoca KOX Bloodcul- ture BC Clinical Isolates Collected in U.S.A. Hospitals M. Castanheira, L. M. Deshpande, R. E. Mendes, R. N. Jones; JMI Lab., N Liberty, IA. C2-692 OqxAB, a Quinolone and Olaquindox Efflux Pump, is Widely Distributed Among Multidrug-Resistant MDR Klebsiella pneumoniae of Human Origin in the Northeast U.S.A.

F. Perez

1 , S. Rudin 1 , S. Marshall 1 , L. Chen 2 , P. Coakley 3 , B. N. Kreiswirth 2 , D. van Duin 4 , D. L. Paterson 5 , R. A. Bonomo 1 ; 1 VAMC, Cleveland, OH, 2 UMDNJ, Newark, NJ, 3 CWRU, Cleveland, OH, 4 Cleveland Clinic, Cleve- land, OH, 5 Univ. of Queensland, Brisbane, Australia. C2-693 First Detection of Klebsiella pneumoniae Isolates Harboring qnr Genes in Japan

H. Okade

1,2 , S. Nakagawa 2 , N. Nomura 2 , J. Mitsuyama 2 , Y. Yamagishi 1 , H. Mikamo 1 ; 1 Aichi Med. Univ., Aichi, Japan, 2 Res. Lab., Toyama Chemical Co., Ltd., Toyama, Japan. C2-694 Molecular Characterization of ơ-Lactamơ-Lactamase In- hibitor Combinations BLBI - Resistant Isolates from Colombia

L. J. Rojas

1 , A. Correa 1 , E. de La Cadena 1 , M. F. Mojica 1 , J. P. Quinn 2 , R. A. Bonomo 3 , M. V. Villegas 1 , Colombian Nosocomial Resistance Study Group; 1 CIDEIM, Cali, Colombia, 2 AstraZeneca, Waltham, MA, 3 VAMC Cleveland, Cleveland, OH. C2-695 Ceftriaxone Resistance among Salmonella Isolates from Humans in the United States, 1996-2010

J. L. Reynolds

1,2 , J. M. Whichard 1 , B. E. Karp 1 ; 1 CDC, Atlanta, GA, 2 Atlanta Res. and Ed. Fndn., Decatur, GA. C2-696 Quinolone Resistance Mechanisms and Molecular Epidemi- ology of Salmonella spp

C. Ballesté-Delpierre

1 , A. Fàbrega 1 , A. Dehn Lunn 2 , M. Solé 1 , M. Jiménez de Anta 1 , J. Vila 1 ; 1 CRESIB-Hosp. Clínic, UB, Barcelona, Spain, 2 Univ. of Sheffield, Sheffield, United Kingdom. 92 SCIENTIFIC SESSIONS September 9-12 | C2-697 CTX-M-5-Coding Plasmids of Nosocomial Salmonella Typhimurium Clone Circulating for a Long Time in Russia, Belarus, and Kazakhstan V. Kozyreva 1 , E. Ilina 2 , A. Carattoli 3 , M. Edelstein 1 , R. Kozlov 1 ; 1 Inst. of Antimicrobial Chemotherapy, Smolensk, Russian Federation, 2 Res. Inst. of Physical-Chemical Med., Moscow, Russian Federation, 3 Inst. Superiore di Sanità, Rome, Italy. C2-698 Characterisation of Antimicrobial Resistance Patterns and Integrons among Salmonella enterica serovar Enteritidis Isolates in Taiwan and Development of Macroarray for Their Detection

H. Tsen

1 , J. Pang 2,3 ; 1 Hung-Kuang Univ., Taichung, Taiwan, 2 Vanung Univ., Tao-Yuan, Taiwan, 3 Vanung Univ., Tao Yuan, Taiwan. C2-699 A 3 Year Study of Changing Epidemiology, Seasonal Patterns, Antibiotic Resistance and Racial Prediliction of Shigella at Qatar

G. Wilson; Hamad Med. Corp., Doha, Qatar. C2-700